This article explores how health insurers are combating growing fraud, and whether more actions are needed.

RGA completed an in-depth study looking at assumptions and experience for lapses and mortality at the end of the level premium period for level term business.

French Translation

Although healthcare provider fraud has historically not received a great deal of attention from consumers and the mainstream media, it is becoming an increasingly costly and troublesome fraud for insurers. Dr Dhiraj Goud, Chief Manager, Health Services, RGA Services ...

RGA provides guidance on developing CI definitions that are clinically correct, clear, accessible and sensible. 

RGA reviews significant facts about melanoma of the skin and its pre-malignant conditions, as well as changes in the staging protocol for skin cancer. RGA also discusses prostate cancer statistics, risk factors and the histological grading of prostate cancer dif...

The SOA’s Product Development Section Council and Committee on Life Insurance Research engaged RGA to research the magnitude and impact of the “shock lapse” at the end of the level premium period.